C

네오크레마

311390KOSDAQ기타 식품 제조업

52.0 / 100

Reference Date: 2026-04-13

Financial Score22.5 / 40
News Sentiment12.5 / 25
Momentum5.0 / 20
Disclosure12.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Declined 8.8% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Neocrema is a functional food ingredient company specializing in microbiome-based products, producing functional sugars and peptides that offer health benefits such as gut environment improvement and blood sugar suppression. Through its subsidiary BB&C, the company diversifies its portfolio with materials and healthcare products, while expanding its market by developing alternative sweeteners and researching skin microbiota. The company also holds international certifications like Halal and Kosher for global exports.

Number of Employees

70people

Average Salary

54.9M KRW

Score Calculation Basis

Detailed Financial Score

PER
17.97Industry Average 13.533.0Point

Higher than industry avg (caution)

PBR
0.37Industry Average 0.645.5Point

Lower than industry avg (good)

ROE
3.58Industry Average 2.724.0Point

In line with industry avg

Debt Ratio
10.64Industry Average 11.914.0Point

In line with industry avg

Trend 2023~20256.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲82.7% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲267.7% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -2.3% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 4,260Won52-week high 10,95052-week low 4,085
1-month return1.0Point

1m -8.78% (falling)

Volume trend3.0Point

Volume flat

Detailed Disclosure

5 totalPositive 1Neutral 4Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-04-07
  • Positive[기재정정]최대주주변경을수반하는주식담보제공계약체결2026-04-07
  • Neutral정기주주총회결과2026-03-26
  • Neutral감사보고서제출2026-03-18
  • Neutral사업보고서 (2025.12)2026-03-18